WO1988002756A3 - Derives peptidiques - Google Patents
Derives peptidiques Download PDFInfo
- Publication number
- WO1988002756A3 WO1988002756A3 PCT/EP1987/000593 EP8700593W WO8802756A3 WO 1988002756 A3 WO1988002756 A3 WO 1988002756A3 EP 8700593 W EP8700593 W EP 8700593W WO 8802756 A3 WO8802756 A3 WO 8802756A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sugar
- peptide
- coupling
- amino acid
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3790635A DE3790635B4 (de) | 1986-10-13 | 1987-10-12 | Verfahren zur Herstellung eines Peptidalkohols und Ausgangsverbindungen dafür |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3634797.3 | 1986-10-13 | ||
DEP3634825.2 | 1986-10-13 | ||
DE3634826 | 1986-10-13 | ||
DE3634825 | 1986-10-13 | ||
DE3634797 | 1986-10-13 | ||
DEP3634826.0 | 1986-10-13 | ||
DEP3712626.1 | 1987-04-14 | ||
DE3712626 | 1987-04-14 | ||
CH3153/87-6 | 1987-08-17 | ||
CH315387 | 1987-08-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1988002756A2 WO1988002756A2 (fr) | 1988-04-21 |
WO1988002756A3 true WO1988002756A3 (fr) | 1988-07-14 |
Family
ID=27509117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1987/000593 WO1988002756A2 (fr) | 1986-10-13 | 1987-10-12 | Derives peptidiques |
Country Status (23)
Country | Link |
---|---|
US (1) | US5656721A (fr) |
JP (2) | JPH0645639B2 (fr) |
KR (1) | KR960016861B1 (fr) |
AU (2) | AU617986B2 (fr) |
BE (1) | BE1003752A4 (fr) |
CA (1) | CA1340985C (fr) |
CH (2) | CH682632A5 (fr) |
DE (1) | DE3790635T1 (fr) |
DK (1) | DK174337B1 (fr) |
ES (1) | ES2007418A6 (fr) |
FI (1) | FI874495A (fr) |
FR (1) | FR2609991A1 (fr) |
GB (2) | GB2199829B (fr) |
GR (1) | GR871567B (fr) |
HU (3) | HU906340D0 (fr) |
IE (1) | IE912442A1 (fr) |
LU (1) | LU87014A1 (fr) |
NL (1) | NL194729C (fr) |
NZ (1) | NZ222133A (fr) |
PL (1) | PL157156B1 (fr) |
PT (1) | PT85904B (fr) |
SE (2) | SE8703938L (fr) |
WO (1) | WO1988002756A2 (fr) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU906340D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Synthesis in solid phase for producing peptonic alcohols |
DE3845000C2 (de) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
EP0329295A1 (fr) * | 1988-02-01 | 1989-08-23 | The Upjohn Company | Peptides inhibant la rénine avec des groupes terminaux polaires |
GB2218102B (en) * | 1988-04-08 | 1992-09-16 | Sandoz Ltd | Calcitonin peptide derivatives |
DE3910667A1 (de) * | 1988-04-11 | 1989-10-19 | Sandoz Ag | Peptidderivate |
GB8813339D0 (en) * | 1988-06-06 | 1988-07-13 | Sandoz Ltd | Improvements in/relating to organic compounds |
FR2638968B1 (fr) * | 1988-11-11 | 1994-10-07 | Sandoz Sa | Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5753627A (en) * | 1988-12-05 | 1998-05-19 | Novartis Ag | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
IT1229514B (it) * | 1989-01-30 | 1991-09-03 | Farmhispania S A A Montme | Glicoconiugati anfifilici sintetici per impiego neurologico. |
DK111489D0 (da) * | 1989-03-08 | 1989-03-08 | Novo Nordisk As | Peptider |
DE4206858A1 (de) * | 1992-03-05 | 1993-09-09 | Behringwerke Ag | Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
TW263437B (fr) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US5710244A (en) * | 1992-12-31 | 1998-01-20 | Labroo; Virender M. | Derivatized calcitonins |
US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
ATE284413T1 (de) * | 1993-08-09 | 2004-12-15 | Sod Conseils Rech Applic | Therapeutische peptid derivate |
US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
JP3896430B2 (ja) * | 1996-07-15 | 2007-03-22 | アークレイ株式会社 | 糖化アミノ化合物の製造方法 |
IL119029A0 (en) * | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
DE69816808T2 (de) | 1997-05-13 | 2004-04-15 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Somatostatin agoniste zur reduzierung von körpergewicht |
US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
EP0981364B1 (fr) | 1997-05-13 | 2006-03-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Procede et compositions pour traiter l'hyperlipidemie |
DE69943039D1 (de) * | 1998-02-13 | 2011-01-27 | Amylin Pharmaceuticals Inc | Neue verbindungen mit gemischter amylin aktivität |
US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
US20050037490A1 (en) * | 1999-10-29 | 2005-02-17 | Lawrence Rosenberg | Medium for preparing dedifferentiated cells |
US7589061B2 (en) * | 2001-04-23 | 2009-09-15 | Mallinckrodt Inc. | Tc and Re labeler radioactive glycosylated octreotide derivatives |
DK1401863T3 (da) | 2001-06-08 | 2009-05-25 | Ipsen Pharma | Kimære somatostatin-dopamin-analoge |
DE60309847T2 (de) * | 2002-02-27 | 2007-10-18 | Ferring B.V. | Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
JP2009506076A (ja) | 2005-08-26 | 2009-02-12 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | 三叉神経疼痛のための薬物送達のための治療手順 |
EP1787658B1 (fr) | 2005-11-10 | 2012-03-14 | CHEMI S.p.A. | Formulations à libération prolongée contenant des inhibiteurs de l'hormone de croissance analogues de la somatostatine |
WO2008011168A2 (fr) * | 2006-07-21 | 2008-01-24 | Amgen Inc. | Antagonistes peptidiques glycosylés du récepteur de la bradykinine de type b1 |
WO2008095063A1 (fr) | 2007-01-31 | 2008-08-07 | Dana-Farber Cancer Institute, Inc. | Peptides p53 stabilisés et utilisations de ceux-ci |
EP2508531B1 (fr) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Polypeptides piqués |
WO2009040363A1 (fr) | 2007-09-25 | 2009-04-02 | Glycom Aps | Glycoprotéines et cellules glycosylées, et procédé pour les préparer |
AU2008323683B2 (en) * | 2007-11-09 | 2014-10-02 | University Of Tennessee Research Foundation | Anti-inflammatory quinic acid derivatives for oral administration |
JP5799397B2 (ja) | 2008-06-12 | 2015-10-28 | イプセン・バイオイノベーション・リミテッドIpsen Bioinnovation Limited | 癌の抑制 |
EP2719392B1 (fr) | 2008-06-12 | 2019-07-24 | Ipsen Bioinnovation Limited | Protéines de fusion pour leur utilisation dans le traitement de l'acromégalie |
WO2010089757A2 (fr) * | 2008-11-07 | 2010-08-12 | Usv Limited | Procédé amélioré de synthèse d'un octapeptide cyclique |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
US9422357B2 (en) | 2011-09-04 | 2016-08-23 | Glytech, Inc. | Glycosylated polypeptide and drug composition containing said polypeptide |
US9441024B2 (en) | 2011-09-04 | 2016-09-13 | Glytech, Inc. | Glycosylated polypeptide and drug composition containing said polypeptide |
AU2012326026B2 (en) | 2011-10-18 | 2017-04-13 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
WO2013123267A1 (fr) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Macrocycles peptidomimétiques réticulés par triazole et par thioéther |
CN112500466B (zh) | 2012-02-15 | 2022-05-03 | 艾瑞朗医疗公司 | 拟肽大环化合物 |
AU2013337388B2 (en) | 2012-11-01 | 2018-08-02 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
WO2014197938A1 (fr) | 2013-06-13 | 2014-12-18 | Antisense Therapeutics Ltd | Polythérapie |
BR112017005598A2 (pt) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | macrociclos peptidomiméticos e usos dos mesmos |
JP7030517B2 (ja) | 2015-01-07 | 2022-03-07 | トライジェミナ, インコーポレイテッド | マグネシウム含有オキシトシン製剤および使用の方法 |
KR20170129879A (ko) | 2015-03-20 | 2017-11-27 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
EP3713545A1 (fr) | 2017-11-22 | 2020-09-30 | Dauntless 1, Inc. | Formulations de composé thérapeutique |
EP3713660A1 (fr) | 2017-11-22 | 2020-09-30 | Dauntless 1, Inc. | Dispositif d'émulsification de membrane pour la création de microsphères |
WO2020005842A1 (fr) | 2018-06-25 | 2020-01-02 | Dauntless 2, Inc. | Dispositif d'émulsification membranaire avec impulseur pour la création de microsphères |
CN114026107A (zh) | 2019-04-16 | 2022-02-08 | 巴克姆股份公司 | 二硫键肽的生产 |
CA3199254A1 (fr) * | 2020-10-22 | 2022-04-28 | The Trustees Of Indiana University | Conceptions moleculaires d'analogues d'insuline sensibles au glucose et clivables par le glucose |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0089290A1 (fr) * | 1982-03-15 | 1983-09-21 | ANVAR Agence Nationale de Valorisation de la Recherche | Conjugués d'haptènes et de muramyl-peptides, doués d'activité immunogène et compositions les contenant |
EP0157753A1 (fr) * | 1984-03-26 | 1985-10-09 | TECHLAND, Société Anonyme | Dérivés de la somatostatine, procédés de synthèse, préparation pour usage vétérinaire contenant ces dérivés et méthode pour le traitement d'animaux |
DE3439610A1 (de) * | 1984-10-30 | 1986-04-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254023A (en) * | 1979-10-16 | 1981-03-03 | Pennwalt Corporation | Synthesis of peptide alcohols by the solid phase method |
US4280953A (en) * | 1979-11-08 | 1981-07-28 | The Salk Institute For Biological Studies | Glycosylated analogs of somatostatin |
DE19375086I2 (de) * | 1979-11-27 | 2003-01-09 | Novartis Ag | Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung |
US4444683A (en) * | 1982-11-17 | 1984-04-24 | University Of Utah | Glycosylated insulin derivatives |
US4483792A (en) * | 1982-11-17 | 1984-11-20 | Kim Wan S | Glycosylated insulin derivatives |
FR2546163B1 (fr) * | 1983-05-16 | 1987-10-09 | Centre Nat Rech Scient | Nouveaux derives acyles hydrosolubles de peptides ou d'amino-acides, leur preparation et leur application |
FR2548673B1 (fr) * | 1983-07-05 | 1985-10-04 | Essilor Int | Polymeres supports de produits actifs relargables et leur procede de preparation |
US4564998A (en) * | 1984-10-19 | 1986-01-21 | Westinghouse Electric Corp. | Coil winding methods and apparatus |
EP0192611A3 (fr) * | 1985-02-20 | 1988-05-11 | Ciba-Geigy Ag | Dérivés d'hexoses acylées et leur méthode de préparation |
JPS61264260A (ja) * | 1985-05-17 | 1986-11-22 | Rikagaku Kenkyusho | アルデヒド化多孔性高分子材料によるタンパク質の除去方法 |
CA1337041C (fr) * | 1985-10-09 | 1995-09-19 | Brett Alan Evans | Compositions granulaires de detergent, a solubilite amelioree |
SE8506094D0 (sv) * | 1985-12-20 | 1985-12-20 | Astra Laekemedel Ab | New antibacterial agents and intermediates therefor |
JPS63165410A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製造方法 |
JPS63165411A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製法 |
HU906340D0 (en) * | 1986-10-13 | 1991-04-29 | Sandoz Ag | Synthesis in solid phase for producing peptonic alcohols |
US4859736A (en) * | 1987-03-30 | 1989-08-22 | Ciba-Geigy Corporation | Synthetic polystyrene resin and its use in solid phase peptide synthesis |
CH679045A5 (fr) * | 1987-06-29 | 1991-12-13 | Sandoz Ag |
-
1987
- 1987-10-01 HU HU906340A patent/HU906340D0/hu unknown
- 1987-10-01 HU HU906341A patent/HU906341D0/hu unknown
- 1987-10-01 HU HU874432A patent/HU206890B/hu not_active IP Right Cessation
- 1987-10-01 NL NL8702345A patent/NL194729C/nl not_active IP Right Cessation
- 1987-10-07 LU LU87014A patent/LU87014A1/fr unknown
- 1987-10-07 FR FR8713949A patent/FR2609991A1/fr active Granted
- 1987-10-09 GB GB8723737A patent/GB2199829B/en not_active Expired - Lifetime
- 1987-10-09 BE BE8701187A patent/BE1003752A4/fr not_active IP Right Cessation
- 1987-10-12 KR KR1019870011265A patent/KR960016861B1/ko not_active IP Right Cessation
- 1987-10-12 PT PT85904A patent/PT85904B/pt unknown
- 1987-10-12 DK DK198705327A patent/DK174337B1/da not_active IP Right Cessation
- 1987-10-12 NZ NZ222133A patent/NZ222133A/xx unknown
- 1987-10-12 DE DE19873790635 patent/DE3790635T1/de active Pending
- 1987-10-12 CH CH1353/89A patent/CH682632A5/de not_active IP Right Cessation
- 1987-10-12 SE SE8703938A patent/SE8703938L/ not_active Application Discontinuation
- 1987-10-12 PL PL1987268173A patent/PL157156B1/pl unknown
- 1987-10-12 FI FI874495A patent/FI874495A/fi not_active Application Discontinuation
- 1987-10-12 JP JP62257047A patent/JPH0645639B2/ja not_active Expired - Lifetime
- 1987-10-12 GR GR871567A patent/GR871567B/el unknown
- 1987-10-12 CH CH3804/90A patent/CH680512A5/de not_active IP Right Cessation
- 1987-10-12 WO PCT/EP1987/000593 patent/WO1988002756A2/fr active Application Filing
- 1987-10-12 AU AU79564/87A patent/AU617986B2/en not_active Ceased
- 1987-10-13 CA CA000549140A patent/CA1340985C/fr not_active Expired - Lifetime
- 1987-10-13 ES ES8702913A patent/ES2007418A6/es not_active Expired
-
1988
- 1988-01-12 GB GB8800537A patent/GB2199831B/en not_active Expired - Lifetime
-
1990
- 1990-06-04 JP JP2147161A patent/JP2744910B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-03 AU AU80150/91A patent/AU634664B2/en not_active Expired
- 1991-07-12 IE IE244291A patent/IE912442A1/en unknown
-
1993
- 1993-04-07 SE SE9301172A patent/SE518630C2/sv unknown
-
1994
- 1994-07-07 US US08/272,704 patent/US5656721A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0089290A1 (fr) * | 1982-03-15 | 1983-09-21 | ANVAR Agence Nationale de Valorisation de la Recherche | Conjugués d'haptènes et de muramyl-peptides, doués d'activité immunogène et compositions les contenant |
EP0157753A1 (fr) * | 1984-03-26 | 1985-10-09 | TECHLAND, Société Anonyme | Dérivés de la somatostatine, procédés de synthèse, préparation pour usage vétérinaire contenant ces dérivés et méthode pour le traitement d'animaux |
DE3439610A1 (de) * | 1984-10-30 | 1986-04-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1988002756A3 (fr) | Derives peptidiques | |
CA2155762A1 (fr) | Mothode de modification de proteine | |
WO1995013297A3 (fr) | Compositions immunogenes ameliorees agissant contre la gastrine humaine 17 | |
EP0640622A4 (fr) | Derive de polysaccharide et vehicule de medicament. | |
AU5707294A (en) | 3,3 diphenyl prop-2-yl amino acid derivatives and their use as tachykinin antagonists | |
CA2168113A1 (fr) | Derives de peptides, agents therapeutiques | |
EP0130779A3 (fr) | Composition pharmaceutique pour résorption dans l'intestin | |
IL86782A (en) | Amino acid derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same | |
HUP9800049A3 (en) | Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf | |
CA2109322A1 (fr) | Analogues de bombesine | |
AU2669688A (en) | 1,7-annelated indolecarboxylic acid esters and amides | |
EP0233013A3 (fr) | Enzyme modifié | |
CA2048425A1 (fr) | Polypeptide ayant des proprietes d'interaction avec la thrombine | |
EP0225020A3 (fr) | Peptides comprenant dans leur séquence des unités sélectionnées parmi les restes d'acides aminés 17 à 24 du VIP | |
NZ231353A (en) | Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives | |
AU6927087A (en) | 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3- substituted-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters | |
EP0791601A3 (fr) | Agent améliorant la formation d'os et inhibitant la résorption osseuse | |
IL81800A0 (en) | 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same | |
EP0228192A3 (fr) | Oligopeptides-inhibiteurs de la rénine, leur préparation et leur utilisation | |
IE873239L (en) | Variants of hirudin | |
AU579672B2 (en) | An improved chopper harvester for sugar cane and the like crops | |
AU585167B2 (en) | Novel substrate peptides | |
MY102979A (en) | Peptide derivatives | |
EP0199257A3 (fr) | Esters de l'acide L-aminodicarboxylique et une composition comestible les contenant en tant qu'édulcorants | |
WO1995009643A6 (fr) | Inhibiteur de l'activite de l'endotheline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT CH DE |
|
ENP | Entry into the national phase |
Ref document number: 1987 9028 Country of ref document: AT Date of ref document: 19880421 Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT CH DE |
|
RET | De translation (de og part 6b) |
Ref document number: 3790635 Country of ref document: DE Date of ref document: 19881006 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3790635 Country of ref document: DE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8607 |